Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 117
of 6Next
1:
Burty C, Pavel S, Ghomari K, Vermersch A, Christian B, Pouaha J, Yazdanpanah Y, May T, Rabaud C.
No Abstract
Tolerability of fosamprenavir/ritonavir associated with zidovudine-lamivudine used as postexposure prophylaxis for HIV infection.
J Acquir Immune Defic Syndr. 2008 Nov 1;49(3):334-6. No abstract available.
PMID: 18978479 [PubMed - in process]
2:
Pineda JA, Pérez-Elías MJ, Peña JM, Luque I, Rodríguez-Alcantara F; Fosamprenavir Expanded Access Program Group.
Abstract
Low rate of adverse hepatic events associated with fosamprenavir/ritonavir-based antiretroviral regimens.
HIV Clin Trials. 2008 Sep-Oct;9(5):309-13.
PMID: 18977719 [PubMed - in process]
3:
Marcelin AG, Flandre P, Molina JM, Katlama C, Yeni P, Raffi F, Antoun Z, Ait-Khaled M, Calvez V.
Abstract
Genotypic resistance analysis of the virological response to fosamprenavir/ritonavir in protease inhibitor-experienced patients in CONTEXT and TRIAD clinical trials.
Antimicrob Agents Chemother. 2008 Oct 13. [Epub ahead of print]
PMID: 18852278 [PubMed - as supplied by publisher]
4:
Pea F, Tavio M, Pavan F, Londero A, Bresadola V, Adani GL, Furlanut M, Viale P.
Abstract
Drop in trough blood concentrations of tacrolimus after switching from nelfinavir to fosamprenavir in four HIV-infected liver transplant patients.
Antivir Ther. 2008;13(5):739-42.
PMID: 18771060 [PubMed - indexed for MEDLINE]
5:
von Hentig N, Förster AK, Kuczka K, Klinkhardt U, Klauke S, Gute P, Staszewski S, Harder S, Graff J.
Abstract
Platelet-leucocyte adhesion markers before and after the initiation of antiretroviral therapy with HIV protease inhibitors.
J Antimicrob Chemother. 2008 Nov;62(5):1118-21. Epub 2008 Aug 27.
PMID: 18753189 [PubMed - in process]
6:
Mahmoud KA, Luong JH.
Abstract
Impedance method for detecting HIV-1 protease and screening for its inhibitors using ferrocene-peptide conjugate/Au nanoparticle/single-walled carbon nanotube modified electrode.
Anal Chem. 2008 Sep 15;80(18):7056-62. Epub 2008 Aug 16.
PMID: 18707132 [PubMed - indexed for MEDLINE]
7:
Calza L, Manfredi R, Pocaterra D, Chiodo F.
Abstract
Efficacy and tolerability of a fosamprenavir-ritonavir-based versus a lopinavir-ritonavir-based antiretroviral treatment in 82 therapy-naïve patients with HIV-1 infection.
Int J STD AIDS. 2008 Aug;19(8):541-4.
PMID: 18663041 [PubMed - indexed for MEDLINE]
8:
[No authors listed]
No Abstract
FDA notifications. Fosamprenavir label is updated.
AIDS Alert. 2008 Feb;23(2):21-2. No abstract available.
PMID: 18578033 [PubMed - indexed for MEDLINE]
9:
Cao YJ, Smith PF, Wire MB, Lou Y, Lancaster CT, Causon RC, Bigelow GE, Martinez E, Fuchs EJ, Radebaugh C, McCabe S, Hendrix CW.
Abstract
Pharmacokinetics and pharmacodynamics of methadone enantiomers after coadministration with fosamprenavir-ritonavir in opioid-dependent subjects.
Pharmacotherapy. 2008 Jul;28(7):863-74.
PMID: 18576901 [PubMed - indexed for MEDLINE]
10:
Pinheiro Edos S, Antunes OA, Fortunak JM.
Abstract
A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.
Antiviral Res. 2008 Sep;79(3):143-65. Epub 2008 Jun 2. Review.
PMID: 18571246 [PubMed - indexed for MEDLINE]
11:
Busti AJ, Bain AM, Hall RG 2nd, Bedimo RG, Leff RD, Meek C, Mehvar R.
Abstract
Effects of atazanavir/ritonavir or fosamprenavir/ritonavir on the pharmacokinetics of rosuvastatin.
J Cardiovasc Pharmacol. 2008 Jun;51(6):605-10.
PMID: 18520949 [PubMed - indexed for MEDLINE]
12:
Collier AC, Tierney C, Downey GF, Eshleman SH, Kashuba A, Klingman K, Vergis EN, Pakes GE, Rooney JF, Rinehart A, Mellors JW; AIDS Clinical Trials Group Protocol A5143 Team.
Abstract
Randomized study of dual versus single ritonavir-enhanced protease inhibitors for protease inhibitor-experienced patients with HIV.
HIV Clin Trials. 2008 Mar-Apr;9(2):91-102.
PMID: 18474494 [PubMed - indexed for MEDLINE]
13:
[No authors listed]
No Abstract
FDA notifications. FDA approves NDA for Lexiva.
AIDS Alert. 2007 Dec;22(12):142. No abstract available.
PMID: 18415960 [PubMed - indexed for MEDLINE]
14:
Sax PE.
No Abstract
Lower dose of ritonavir approved for use with fosamprenavir.
AIDS Clin Care. 2007 Dec;19(12):106. No abstract available.
PMID: 18399004 [PubMed - indexed for MEDLINE]
15:
Masquelier B, Assoumou KL, Descamps D, Bocket L, Cottalorda J, Ruffault A, Marcelin AG, Morand-Joubert L, Tamalet C, Charpentier C, Peytavin G, Antoun Z, Brun-Vézinet F, Costagliola D; ANRS Resistance Study Group.
Abstract
Clinically validated mutation scores for HIV-1 resistance to fosamprenavir/ritonavir.
J Antimicrob Chemother. 2008 Jun;61(6):1362-8. Epub 2008 Apr 4.
PMID: 18390885 [PubMed - indexed for MEDLINE]
16:
Smith KY, Weinberg WG, Dejesus E, Fischl MA, Liao Q, Ross LL, Pakes GE, Pappa KA, Lancaster CT; ALERT (COL103952) Study Team.
Free in PMC
Fosamprenavir or atazanavir once daily boosted with ritonavir 100 mg, plus tenofovir/emtricitabine, for the initial treatment of HIV infection: 48-week results of ALERT.
AIDS Res Ther. 2008 Mar 28;5:5.
PMID: 18373851 [PubMed]
17:
Molina JM.
Abstract
Efficacy and safety of once-daily regimens in the treatment of HIV infection.
Drugs. 2008;68(5):567-78. Review.
PMID: 18370438 [PubMed - indexed for MEDLINE]
18:
Delgado O, Riera M, Murillas J, Ventayol P.
Free Full Text
[Plasma levels following the switch from amprenavir to fosamprenavir in HIV-infected patients under antiretroviral treatment with lopinavir/ritonavir]
Enferm Infecc Microbiol Clin. 2008 Mar;26(3):182-3. Spanish. No abstract available.
PMID: 18358222 [PubMed - indexed for MEDLINE]
19:
Dailly E, Raffi F, Biron C, Allavena C, Jolliet P.
Abstract
Impact of nevirapine or efavirenz co-administration on ritonavir-boosted amprenavir pharmacokinetics in HIV-infected patients.
Fundam Clin Pharmacol. 2008 Feb;22(1):101-4.
PMID: 18251726 [PubMed - indexed for MEDLINE]
20:
Izzedine H, Brocheriou I, Valantin MA, Camous L, Bourry E, Baumelou A, Deray G, Katlama C.
Abstract
A case of acute renal failure associated with diffuse infiltrative lymphocytosis syndrome.
Nat Clin Pract Nephrol. 2008 Feb;4(2):110-4.
PMID: 18227804 [PubMed - indexed for MEDLINE]
Items 1 - 20 of 117
of 6Next